Intriguing data from other laboratories have shown evidence of acute effects of solubilized P protein and related fragments in vitro and in vivo in the rat brain. As discussed below, it is difficult to assess the physiological significance of these short term effects with solubilized peptides which have never been measured in human brain and how they may relate to the complex, insoluble amyloid deposits known to occur in AD brain. In contrast, we have investigated the long-term fate of Alzheimer's amyloid cores injected into rat hippocampus and observed neuron loss, Alz-50 and ubiquitin immunoreactivity, and amyloid phagocytosis and migration to vessel walls (Preliminary studies). We now propose to extend and refine this work using progressively more complex synthetic amyloid deposits to investigate the role of specific molecular and cellular elements in plaque pathogenesis. In particular, in addition to putative neurotoxic effects, we propose to explore the interaction between synthetic amyloid deposits and heparin binding growth factors and their relationships to cellular elements involved in AD.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (SRC (33))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Whittier Institute for Diabetes & Endoc
La Jolla
United States
Zip Code
Attar, Aida; Ripoli, Cristian; Riccardi, Elisa et al. (2012) Protection of primary neurons and mouse brain from Alzheimer's pathology by molecular tweezers. Brain 135:3735-48
Frautschy, Sally A; Cole, Greg M (2011) What was lost in translation in the DHA trial is whom you should intend to treat. Alzheimers Res Ther 3:2
Frautschy, Sally A (2010) Thinking outside the box about COX-1 in Alzheimer's disease. Neurobiol Dis 38:492-4
Cole, Greg M; Frautschy, Sally A (2010) Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease. CNS Neurol Disord Drug Targets 9:140-8
Frautschy, Sally A; Cole, Greg M (2010) Why pleiotropic interventions are needed for Alzheimer's disease. Mol Neurobiol 41:392-409
Ma, Qiu-Lan; Galasko, Douglas R; Ringman, John M et al. (2009) Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. Arch Neurol 66:448-57
Hu, Shuxin; Begum, Aynun N; Jones, Mychica R et al. (2009) GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals. Neurobiol Dis 33:193-206
Hu, Shuxin; Ying, Zhe; Gomez-Pinilla, Fernando et al. (2009) Exercise can increase small heat shock proteins (sHSP) and pre- and post-synaptic proteins in the hippocampus. Brain Res 1249:191-201
Cole, Greg M; Teter, Bruce; Frautschy, Sally A (2007) Neuroprotective effects of curcumin. Adv Exp Med Biol 595:197-212
Ma, Qiu-Lan; Harris-White, Marni E; Ubeda, Oliver J et al. (2007) Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models. J Neurochem 103:1594-607

Showing the most recent 10 out of 33 publications